-
Will Pharma Sector Get its Mojo Back?
Despite this challenging macro environment, we remain optimistic about the growth outlook of the Indian pharmaceutical companies
-
DRL on the mat despite 10x profit rise
The company's profit in Q4 has increased from Rs 87.5 crore to Rs 959.5 crore, while the market was expecting a profit of around Rs 1,100 crore
-
Trading ideas: four stock recommendations for November 12
Anand Rathi is bullish on Balrampur Chini Mills with a price target of Rs 365 per share.
-
Auto stocks, RIL, Dr. Reddy’s Labs, Shree Cement in focus
Shares of Reliance Industries (RIL) will be in focus. Jio and Google announced that JioPhone Next, will be available in stores from Diwali.
-
Trading ideas: 6 stocks recommendations for Tuesday
Nirmal Bang is bullish on State Bank of India with a price target of Rs 535 per share.
-
CLSA is bullish on these two pharma stocks
Most pharma companies provided a broad roadmap on the transition to complex generic products while maintaining a calibrated R&D allocation strategy
-
Single-dose Sputnik Light set for roll out in September
The vaccine is expected to cost approximately Rs 750 per vial and will be available in limited quantities initially.
-
ICICI Lombard, Dr Reddy’s join hands for cashless outpatient service
Outpatients will get the benefit of doctor consultations, pathology laboratories and diagnostics services, pharmacies, and insurance
-
Should you buy, sell or hold Dr Reddy’s post sharp fall?
The pharma major reported a consolidated profit of Rs 570.8 crore for the quarter ended June 2021, 1.5% down from the year-ago period
-
Sputnik V to be available during Sep- Oct: Dr Reddy's
Dr Reddy's is in discussions with RDIF for ramping up supplies
